万亿资金，涌入！

Group 1 - The A-share market showed strong growth in growth style, with notable performances in the pharmaceutical and semiconductor sectors, where multiple related ETFs rose over 5% in a single day [1] - In December 2025, the A500 and Sci-Tech bonds became significant directions for capital inflow, with several related ETFs seeing net inflows exceeding 10 billion yuan [2][8] - The Hong Kong pharmaceutical sector performed strongly, with multiple ETFs in innovative drugs and medical devices rising over 6%, indicating a robust market for innovative pharmaceuticals [4][5] Group 2 - The semiconductor sector experienced a hot market, with multiple ETFs related to semiconductor chips, big data, AI, and cloud computing showing significant gains, with some ETFs rising over 5% [6][7] - In December 2025, the net inflow for A500-related ETFs exceeded 20 billion yuan, with specific ETFs like the Southern CSI A500 ETF and Huatai-PB CSI A500 ETF seeing net inflows over 20 billion yuan each [9] - The outlook for the Hong Kong market in 2026 suggests a potential recovery in corporate earnings, particularly in sectors benefiting from overseas demand and competitive industry leaders, with AI, new consumption, pharmaceuticals, and dividends highlighted as key focus areas [12]